skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreProduct loginProductLogin
Global Search Configuration

About Ayisha

UK

1+ years of experience

Ayisha Sharma Headshot
Ayisha Sharma report on a drug development across range of therapeutic areas including oncology, neurology and rare diseases. She particularly interested in writing on psychiatry and novel drug development in this space, such as psychedelics, and the emergence of microbiome modulators.

She joined Informa in 2021.

 

Her current areas of expertise are rare diseases, psychiatry and microbiome modulation.

 

She previously worked as a reporter at BioPharm Insight, where she covered the beats of hematology, oncology and rare diseases.

 

Her biggest achievement was writing an article about what big pharma’s must do to help tackle antimicrobial resistance and the future of consolidation and partnerships in this space, based on an interview with the Access to Medicines foundation. 

Specialties

  • Biotech
  • Clinical Trials
  • Companies
  • Drug Development
  • Product Reviews And Approvals

Ayisha writes For

Analyst Articles